Less Ads, More Data, More Tools Register for FREE

Pin to quick picksM P Evans Regulatory News (MPE)

Share Price Information for M P Evans (MPE)

Share Price is delayed by 15 minutes
Get Live Data
1,592.00    44.00 (2.84%)
Bid:
1,580.00
Ask:
1,586.00
Spread: 6.00 (0.38%)
Market Cap: £827.82m
MPE Live PriceLast checked at - London Stock Exchange

Intraday M P Evans Share Chart

Director/PDMR Shareholding

16 Dec 2025 07:00

RNS Number : 6553L
M. P. Evans Group PLC
16 December 2025
 

M.P. EVANS GROUP PLC

("Company" or "M.P. Evans")

 

GRANT OF SHARE OPTIONS

 

On 15 December 2025, in line with its policy of deferring half the executive annual bonus into nil-cost share options, the Company granted an option under the M.P. Evans Group PLC Long Term Incentive Scheme to each of Mr Matthew Coulson, the chief executive, and Mr Luke Shaw, the chief financial officer. They may subscribe for 15,119 and 10,134 shares of 10p each respectively in the Company at a nil cost exercise price. No additional performance criteria will attach to the deferred-bonus awards since the original bonuses are performance related. These options are exercisable at any time between 15 December 2028 and 14 December 2035.

 

The information set out below is provided in accordance with the requirements of Article 19(3) of Regulation (EU) No. 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse, as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018, as amended ("UK MAR").

 

1

Details of the persons discharging managerial responsibilities / person closely associated

a)

Name

Matthew Coulson

2

Reason for the notification

a)

Position/status

Chief executive

b)

Initial notification /Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

M.P. Evans Group PLC

b)

LEI

2138003IBXJUCR4SZG26

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Shares of 10p per share in the capital of M.P. Evans Group PLC (10p shares)

Identification code

ISIN: GB0007538100

b)

Nature of the transaction

Grant of options over 10p shares

c)

Price(s) and volume(s)

Exercise Prices per share

Volume

Nil Cost Options

15,119

d)

Aggregated information

- Aggregated volume

- Price

 

Aggregated volume: N/A

Price: N/A

e)

Date of the transaction

15 December 2025

f)

Place of the transaction

Outside a trading venue

 

1

Details of the persons discharging managerial responsibilities / person closely associated

a)

Name

Luke Shaw

2

Reason for the notification

a)

Position/status

Chief financial officer

b)

Initial notification /Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

M.P. Evans Group PLC

b)

LEI

2138003IBXJUCR4SZG26

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Shares of 10p per share in the capital of M.P. Evans Group PLC (10p shares)

Identification code

ISIN: GB0007538100

b)

Nature of the transaction

Grant of options over 10p shares

c)

Price(s) and volume(s)

Exercise Prices per share

Volume

Nil Cost Options

10,134

d)

Aggregated information

- Aggregated volume

- Price

 

Aggregated volume: N/A

Price: N/A

e)

Date of the transaction

15 December 2025

f)

Place of the transaction

Outside a trading venue

 

16 December 2025

Enquiries:

 

M.P. Evans Group PLC

Telephone: +44 (0) 1892 516333

Peter Hadsley-Chaplin, chairman

Matthew Coulson, chief executive

Luke Shaw, chief financial officer

Cavendish Capital Markets (Nomad and joint broker)

Telephone: +44 (0) 20 7220 0500

Matt Goode, George Lawson (Corporate finance)

Tim Redfern, Harriet Ward (ECM)

Canaccord Genuity Limited (Joint broker)

Telephone: +44 (0) 20 7523 4500

Henry Fitzgerald-O'Connor, George Grainger

Hudson Sandler (Financial PR)

Telephone: +44 (0) 20 7796 4133

Charlie Jack, Nick Moore, Francesca Rosser

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHFFLFAIEISESE
Date   Source Headline
8th Mar 20217:00 amRNSNotice of Results and Investor Presentation
15th Jan 20214:28 pmRNSDirector/PDMR Shareholding
7th Jan 20217:00 amRNSCrop and production update
5th Jan 20217:00 amRNSBlock listing Interim Review
23rd Dec 20207:00 amRNSDirector/PDMR Shareholding
10th Dec 20201:41 pmRNSDirector/PDMR Shareholding
7th Dec 20204:36 pmRNSupdate
1st Dec 20207:00 amRNSInvestor presentation
17th Nov 202012:00 pmRNSInvestor Presentation
4th Nov 20203:40 pmRNSHolding(s) in Company
4th Nov 20202:41 pmRNSHolding(s) in Company
14th Sep 20207:00 amRNSHalf-year Report
4th Sep 202011:44 amRNSInvestor Presentation
4th Sep 202010:31 amRNSNotification of interim results
29th Jul 202012:05 pmRNSHolding(s) in Company
24th Jul 20207:00 amRNSH1 trading update
23rd Jul 20209:50 amRNSHolding(s) in Company
20th Jul 20209:21 amRNSDisposal
10th Jul 202011:07 amRNSHolding(s) in Company
1st Jul 20201:00 pmRNSBlock listing Interim Review
1st Jul 20209:46 amRNSTotal Voting Rights
5th Jun 20205:08 pmRNSResult of AGM
5th Jun 20207:00 amRNSTrading Statement
5th Jun 20207:00 amRNSTransaction in Own Shares
2nd Jun 20207:00 amRNSTransaction in Own Shares
1st Jun 20209:40 amRNSTotal Voting Rights
1st Jun 20207:00 amRNSTransaction in Own Shares
21st May 202011:44 amRNSTransaction in Own Shares
20th May 20207:00 amRNSTransaction in Own Shares
19th May 20207:00 amRNSAGM update
19th May 20207:00 amRNSTransaction in Own Shares
18th May 20207:00 amRNSTransaction in Own Shares
13th May 20207:00 amRNSTransaction in Own Shares
11th May 20207:00 amRNSTransaction in Own Shares
7th May 20207:00 amRNSTransaction in Own Shares
6th May 20207:00 amRNSTransaction in Own Shares
5th May 20207:00 amRNSTransaction in Own Shares
1st May 20208:59 amRNSTotal Voting Rights
1st May 20207:00 amRNSTransaction in Own Shares
27th Apr 20207:00 amRNSTransaction in Own Shares
22nd Apr 20207:00 amRNSTransaction in Own Shares
21st Apr 20207:00 amRNSTransaction in Own Shares
20th Apr 20206:15 pmRNSAllotment of Shares and Total Voting Rights
20th Apr 20207:00 amRNSTransaction in Own Shares
17th Apr 20207:00 amRNSTransaction in Own Shares
15th Apr 20207:00 amRNSBlock listing application
15th Apr 20207:00 amRNSTransaction in Own Shares
14th Apr 20207:00 amRNSTransaction in Own Shares
9th Apr 20207:00 amRNSTransaction in Own Shares
8th Apr 20207:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.